<Disease><Name>PORPHYRIA CUTANEA TARDA, TYPE I (PCT)</Name><Synonym /><OMIM><Number>176090</Number><URL>http://omim.org/entry/176090</URL></OMIM><Orphanet><Number>443057</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=443057</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene /><ICD>E80.1</ICD><Summary>rare;autosomal dominant, multifactorial?;- type I (MIM 176090), sporadic type (most common);- type II (MIM 176100), familial type;- type II ?;Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which ;porphyria cutanea tarda; (PCT) is the most common [Handler NS et al. 2017]</Summary><Symptoms><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3062</id><symptom>diabetes mellitus</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2449</id><symptom>heart involvement</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2169</id><symptom>hyperpigmentation</symptom><category>SKIN</category></symtomp><symtomp><id>3222</id><symptom>hypertrichosis</symptom><category>SKIN</category></symtomp><symtomp><id>2468</id><symptom>impaired visual acuity</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2012</id><symptom>photophobia or photosensitive defect in light-exposed area</symptom><category>SKIN</category></symtomp><symtomp><id>2006</id><symptom>skin defects</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>3385</id><symptom>skin, abnormal</symptom><category>SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>1185</id><name>Porphyrins</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1192</id><name>Porphyrins</name><specimen>fecal</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1193</id><name>Porphyrins</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1194</id><name>Porphyrins</name><specimen>erythrocytes</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4598</id><title>Porphyria cutanea tarda: an intriguing genetic disease and marker</title><author>Handler NS,</author><journal>Int J Dermatol</journal><year>2017</year><book /><volume>56</volume><number>6</number><pages>e106-107</pages><co_aut>et al.</co_aut></literature><literature><id>4599</id><title>Hepatic porphyria: A narrative review</title><author>Arora S;</author><journal>Indian J Gastroenterol</journal><year>2016</year><book /><volume>35</volume><number>6</number><pages>405-418</pages><co_aut>et al.</co_aut></literature><literature><id>4600</id><title>Illness Perception and Psychological Distress in Persons with Porphyria Cutanea Tarda</title><author>Andersen J,</author><journal>Acta Derm Venereol</journal><year>2016</year><book /><volume>96</volume><number>5</number><pages>674-678</pages><co_aut>Nordin K, Sandberg S</co_aut></literature><literature><id>4601</id><title>Ocular manifestations in porphyria cutanea tarda</title><author>Gogri PY,</author><journal>BMJ Case Rep</journal><year>2014</year><book /><volume>2014</volume><number>0</number><pages /><co_aut>Misra NS, Misra S</co_aut></literature><literature><id>4602</id><title>Porphyria cutanea tarda with constrictive pericarditis: a rare association</title><author>Jasleen K,</author><journal>Case Rep Dermatol Med</journal><year>2012</year><book /><volume>2012</volume><number>0</number><pages>972162</pages><co_aut>et al.</co_aut></literature><literature><id>2143</id><title>Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda</title><author>Stolzel U</author><journal>Arch Dermatol</journal><year>2003</year><book /><volume>139</volume><number>3</number><pages>309-313</pages><co_aut>et al.</co_aut></literature><literature><id>2144</id><title>Human hereditary hepatic porphyrias</title><author>Nordmann Y</author><journal>Clin Chim Acta</journal><year>2002</year><book /><volume>325</volume><number>0</number><pages>17-37</pages><co_aut>et al.</co_aut></literature><literature><id>2145</id><title>Management of acute and cutaneous porphyrias</title><author>Badminton MN</author><journal>Int J Clin Pract</journal><year>2002</year><book /><volume>56</volume><number>4</number><pages>272-278</pages><co_aut>Elder GH</co_aut></literature><literature><id>2146</id><title>The management of porphyria cutanea tarda</title><author>Sarkany RP</author><journal>Clin Exp Dermatol</journal><year>2001</year><book /><volume>26</volume><number>3</number><pages>225-232</pages><co_aut /></literature><literature><id>786</id><title>Porphyrias</title><author>Nordmann Y</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>333-340</pages><co_aut /></literature><literature><id>794</id><title>The porphyrias</title><author>Anderson KE</author><journal>Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman &amp; Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>437-451</pages><co_aut /></literature></Literatures></Disease>